K_3_16 — Anesthesia and Consciousness: What Going Under Reveals

General anesthesia provides a unique experimental window into consciousness: the ability to reversibly abolish and restore awareness in a controlled clinical setting. Despite over 175 years of practice since William T.G.

K_3_15 — Anesthesia and the Mechanisms of Consciousness Loss

General anesthesia — the reversible abolition of consciousness through pharmacological agents — is one of the most remarkable phenomena in medicine: it routinely eliminates subjective experience in millions of patients d

T_2_18 — Schizophrenia & Psychotic Disorders

Schizophrenia is a severe psychiatric disorder affecting approximately 24 million people worldwide (WHO, 2022), characterized by positive symptoms (hallucinations, delusions, disorganized thought), negative symptoms (anh

T_2_17 — Depression & Mood Disorders

Major Depressive Disorder (MDD) affects an estimated 280 million people worldwide (WHO, 2023) and is the leading cause of disability globally. The neurobiological understanding of depression has undergone a paradigm shif

Y_0_00 — Altered States & Psychedelics: Section Summary

Y_2_08 — Anesthesia, Consciousness, and Awareness

General anesthesia — the pharmacological induction of unconsciousness, amnesia, analgesia, and immobility — is one of the most profound alterations of consciousness that humans routinely produce, yet how anesthetics actu

Y_1_17 — Ketamine Therapy and Dissociative Medicine

Ketamine — a dissociative anesthetic synthesized by Calvin Stevens at Parke-Davis in 1962 and first used clinically by Edward Domino and Guenter Corssen in 1966 — has emerged as a revolutionary treatment for treatment-re

Y_1_13 — Xenon Gas and Nitrous Oxide: Anesthetic Gases as Consciousness Probes

Nitrous oxide (N₂O — "laughing gas") and xenon (Xe — a noble gas) are two anesthetic gases that have served as remarkable probes of consciousness — revealing how the manipulation of a single molecule or atom can dissolve

Y_1_11 — Ketamine: Dissociative Anesthetic and Consciousness Explorer

Ketamine is a dissociative anesthetic — first synthesized by Calvin Stevens in 1962 and introduced into clinical use by Edward Domino and Guenter Corssen (1966) — that has undergone a remarkable transformation from battl

Y_1_21 — Plant Medicine & Alkaloid Chemistry

Alkaloids — nitrogen-containing organic compounds produced by plants as secondary metabolites — constitute one of the most important classes of biologically active molecules in both medicine and human culture. Over 20,00

Y_1_19 — Ibogaine Reset Mechanism

Ibogaine — a naturally occurring psychoactive indole alkaloid extracted from the root bark of Tabernanthe iboga, a shrub native to the equatorial forests of Gabon and Cameroon — has emerged as one of the most pharmacolog

Y_1_20 — Cannabis & Consciousness

Cannabis (Cannabis sativa) is the most widely used psychoactive substance in the world after alcohol and tobacco, consumed by an estimated 192 million people globally (2020, UNODC World Drug Report), and its effects on c

Y_1_18 — Addiction Neurochemistry: Reward Circuits, Tolerance & Therapeutic Frontiers

Addiction — now formally termed substance use disorder (SUD, DSM-5) — is a chronic, relapsing brain disorder characterized by compulsive drug seeking despite harmful consequences, affecting approximately 35 million peopl

Y_1_15 — Micro-Dosing: Sub-Perceptual Psychedelic Use and Cognitive Effects

Micro-dosing — the practice of regularly consuming sub-perceptual doses (typically 1/10th to 1/20th of a standard recreational dose) of psychedelic substances, most commonly LSD (~10–20 micrograms) or psilocybin (~0.1–0.

Y_1_00 — Psychedelics Entheogens: Subfolder Summary

R_4_07 — Venom Evolution and Biochemical Arms Races

Venom — a cocktail of bioactive molecules injected via a specialized delivery apparatus (fangs, stingers, harpoons, nematocysts, spurs) to subdue prey, deter predators, or aid in competition — has evolved independently o